{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:41:20Z","timestamp":1776418880896,"version":"3.51.2"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.yebeh.2003.11.033","type":"journal-article","created":{"date-parts":[[2004,1,27]],"date-time":"2004-01-27T05:22:43Z","timestamp":1075180963000},"page":"197-203","source":"Crossref","is-referenced-by-count":15,"title":["Effects of topiramate on memory performance on the intracarotid amobarbital (Wada) test"],"prefix":"10.1016","volume":"5","author":[{"given":"Svetlana","family":"Kipervasser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fani","family":"Andelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uri","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sari","family":"Nagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itzhak","family":"Fried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miri Y.","family":"Neufeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.yebeh.2003.11.033_BIB1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1528-1157.2001.00516.x","article-title":"Effects of antiepileptic drugs on cognition","volume":"42","author":"Aldenkamp","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.11.033_BIB2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-33046","article-title":"Some common issues in the use of antiepileptic drugs","volume":"22","author":"Asconape","year":"2002","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.yebeh.2003.11.033_BIB3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.52.2.321","article-title":"Cognitive effect of topiramate, gabapentin, and lamotrigine in healthy young adults","volume":"52","author":"Martin","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.11.033_BIB4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00002826-200109000-00005","article-title":"Clinical and electroencephalographic effects of topiramate in patients with epilepsy and healthy volunteers","volume":"24","author":"Mecarelli","year":"2001","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.yebeh.2003.11.033_BIB5","doi-asserted-by":"crossref","unstructured":"Faught E, Wilder BJ, Ramsay RA, et al., for the Topiramate YD Study Group. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology 1996;46:1684\u201390","DOI":"10.1212\/WNL.46.6.1684"},{"key":"10.1016\/j.yebeh.2003.11.033_BIB6","doi-asserted-by":"crossref","unstructured":"Privitera M, Fincham R, Penry J, et al., for the Topiramate YE Study Group. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1000-mg daily dosages. Neurology 1996;46:1678\u201383","DOI":"10.1212\/WNL.46.6.1678"},{"key":"10.1016\/j.yebeh.2003.11.033_BIB7","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1046\/j.1528-1157.2001.41700.x","article-title":"Postmarketing experience with topiramate and cognition","volume":"42","author":"Tatum 4th","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.11.033_BIB8","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1212\/01.WNL.0000063308.22506.19","article-title":"Differential cognitive and behavioral effects of topiramate and valproate","volume":"60","author":"Meador","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.11.033_BIB9","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1528-1157.2000.tb00322.x","article-title":"A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures","volume":"41","author":"Aldenkamp","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.11.033_BIB10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/jnnp.69.5.636","article-title":"Effects of topiramate on cognitive function","volume":"69","author":"Thompson","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.yebeh.2003.11.033_BIB11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-1211(03)00078-0","article-title":"Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients","volume":"54","author":"Kockelmann","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.yebeh.2003.11.033_BIB12","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/01.WNL.0000056637.37509.C6","article-title":"Topiramate and word-finding difficulties in patients with epilepsy","volume":"60","author":"Mula","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.11.033_BIB13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1528-1157.2003.27402.x","article-title":"The effects of adjunctive topiramate on cognitive function in patients with epilepsy","volume":"44","author":"Lee","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.11.033_BIB14","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1528-1157.2000.tb00262.x","article-title":"Abnormal Wada and neuropsychological testing results due to topiramate therapy","volume":"41","author":"McCabe","year":"2000","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505003003925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505003003925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T06:21:23Z","timestamp":1550211683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505003003925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S1525505003003925"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2003.11.033","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}